Chinese english Germany Japanese Korea

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo-

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo- Struktur
2459302-77-1
CAS-Nr.
2459302-77-1
Englisch Name:
7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo-
Synonyma:
Tofacitinib N-Oxopropanenitrile;Tofacitinib N-Oxopropanenitrile. 7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo-
CBNumber:
CB98376533
Summenformel:
C19H21N7O2
Molgewicht:
379.42
MOL-Datei:
2459302-77-1.mol
Request For Quotation

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo- Eigenschaften

Siedepunkt:
643.8±55.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
pka
-2.61±0.10(Predicted)

Sicherheit

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Tofacitinib N-Oxopropanenitrile is an impurity of Tofacitinib(C781351); a Janus kinase inhibitor for treatment of rheumatoid arthritis.

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
 greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8011 55
Jinan Baizhou Biological Technology Co., Ltd. 0531-88987162 18615427082
 2823799053@qq.com China 497 58
Tianjin shijia biomedical technology co., LTD 15022261580;411316762
tjshj1212@163.com China 2359 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
 czbjpharma@126.com China 18488 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
 2885426135@qq.com China 6580 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
 cb5@aikonchem.com China 10529 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233
 3641133981@qq.com China 9380 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234
 2208093734@qq.com China 6348 58
  • Tofacitinib N-Oxopropanenitrile
  • Tofacitinib N-Oxopropanenitrile. 7H-Pyrrolo[2,3-d]pyrimidine-7-propanenitrile, 4-[[(3R,4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-β-oxo-
  • 2459302-77-1
Copyright 2019 © ChemicalBook. All rights reserved